Kenneth J. Hillan Sangamo Therapeutics, Inc (SGMO) insider trading activity

SGMO Quotes by TradingView

Kenneth J. Hillan is of SANGAMO THERAPEUTICS, INC. Currently has a direct ownership of 99,600 shares of SGMO, which is worth approximately $45,816. The most recent transaction as insider was on Jun 12, 2025, when has been sold 25,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 99.6K
33.51% 3M change
33.51% 12M change
Total Value Held $45,816

Kenneth J. Hillan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 12 2025
BUY
Grant, award, or other acquisition
-
25,000 Added 20.06%
99,600 Common Stock
Jun 04 2024
BUY
Grant, award, or other acquisition
-
25,000 Added 25.1%
74,600 Common Stock
Jun 01 2023
BUY
Grant, award, or other acquisition
-
13,900 Added 21.89%
49,600 Common Stock
Feb 25 2022
BUY
Grant, award, or other acquisition
-
12,500 Added 25.93%
35,700 Common Stock
Feb 25 2021
BUY
Grant, award, or other acquisition
-
8,200 Added 26.11%
23,200 Common Stock

Also insider at

ZYME
Zymeworks Inc. Healthcare
Director
ME
23andMe Holding Co. Healthcare
Chief Therapeutics Officer
ZYME
Zymeworks Inc.
KJH

Kenneth J. Hillan

South San Francisco, CA

Track Institutional and Insider Activities on SGMO

Follow SANGAMO THERAPEUTICS, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SGMO shares.

Notify only if

Insider Trading

Get notified when an Sangamo Therapeutics, Inc insider buys or sells SGMO shares.

Notify only if

News

Receive news related to SANGAMO THERAPEUTICS, INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SGMO